Skip to content

Bariatric Surgery in Morbidly Obese Type 2 Diabetic Patients

A randomised trial of adjunction intensive psychological, dietary and cultural management versus standard guidelines-based care to maximise weight loss among high-risk subjects with type 2 diabetes mellitus and morbid obesity treated with bariatric surgery

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12608000080325
Enrollment
68
Registered
2008-02-13
Start date
2008-05-22
Completion date
2009-05-20
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study comprises a randomised trial of intensive “wrap around” management versus standard guideline-based care. Sixty (60) patients with type 2 diabetes and morbid obesity (BMI = 35) will be enrolled. Patients will attend on average nine (9) scheduled study visits over the course of the study. Those found to be eligible after the baseline assessments will be randomised to receive a “wrap around” regimen comprising intensive psychological assessment/counselling, cultural support, intensive dietetic assessment/counselling and an exercise programme or standard guideline-based care in a 1:1 ratio. All participants (i.e. intensive management and standard care) will undergo a bariatric surgery procedure 6-months after randomisation. The total duration of follow-up is 18 months.

Interventions

Intensive “wrap around” regimen comprising intensive psychological assessment/counselling, cultural support, intensive dietetic assessment/counselling and an exercise programme. The duration of this intervention is 6 months pre-operatively and 12 months post-operatively. The exact nature of the regimen will be tailored to the participant on a case by case basis.

Sponsors

Middlemore Clinical Trials
Lead SponsorCharities/Societies/Foundations

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Type 2 diabetes Morbid Obesity - BMI >35

Exclusion criteria

Diabetic nephropathy. A significant malabsorptive or gastrointestinal disorder.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026